The DNA Medicine Institute has received a $222,999 grant from the US government under the Qualifying Therapeutic Discovery Project (QTDP) Program, to advance the development of Universal Blood Sensor, a point-of-care blood diagnostic device.

DMI said that its Universal Blood Sensor offers a full system’s check of a person anywhere, anytime, and with a single drop of blood without the use of a hospital-sized testing center, a phlebotomist, and skilled medical practitioners.

The sensor allows for all disease states from all organs to be analyzed, whether this involves the heart, blood, lungs, brain, kidneys, cancer, or infection and also allows the user to proceed with optimal management in the event of an abnormal state.

DNA Medicine Institute president and chief scientific officer Eugene Chan said that this funding will allow to speed the development of innovations for making vital diagnostic information readily available to all patients regardless of their setting, need, or economic condition.